Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02100358 · ClinicalTrials.gov registry record
Functional MRC With Eovist for Acute Cholecystitis
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 17
- Enrollment target
NCT02100358: Completed study, sponsored by University of California, Davis.
NCT02100358 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02100358 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Functional magnetic resonance cholangiography (fMRC) with gadoxetate disodium (Eovist) is an accurate method of diagnosing acute cholecystitis.
Primary Outcome
The primary outcome measure is the number of positive cases of acute cholecystitis on functional magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-04 |
What the finished NCT02100358 record still lists
NCT02100358 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02100358 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02100358 about?
NCT02100358 is a clinical study titled "Functional MRC With Eovist for Acute Cholecystitis". Functional magnetic resonance cholangiography (fMRC) with gadoxetate disodium (Eovist) is an accurate method of diagnosing acute cholecystitis.
What is the current status of trial NCT02100358?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2013-02. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT02100358?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia